A New Human Paradigm

AnaBios’ ex vivo human-based platform overcomes the cross-species differences commonly encountered in drug development and basic research when using animal based models. The direct study of human biology and pharmacology provides results that are relevant and predictive of clinical outcomes. AnaBios provides contract research services in several areas, including:

  • Cardiac Drug Safety
  • Cardiac Disease
  • Vascular Disease
  • Pain & Itch
  • Liver Disease
  • Kidney Disease
  • Lung Disease